Nebraska Reviews Medical Cannabis Regulations, Proposes New Fees and Labeling Changes
Nebraska’s Medical Cannabis Commission is considering new regulations that would add fees, revise product labeling, and merge licenses, with public feedback invited before final approval
Key Points
- 1Nebraska Medical Cannabis Commission is proposing regulatory amendments, including new fees and updated labeling requirements
- 2A public hearing will be held in Lincoln, with written comments accepted until Thursday night
- 3Proposed changes include a $5,000 application fee, annual fees up to $28,500, and new product licensing fees
- 4Transporter licenses would be merged with product manufacturers, changing how transportation is regulated
- 5Further licensing of establishments is on hold until the new regulations are approved by executive officials
Nebraska’s Medical Cannabis Commission is seeking public input on significant amendments to its regulations, including changes to product labeling and the introduction of a comprehensive fee structure. Residents can attend a hearing at the State Office Building in Lincoln or submit written comments by the end of Thursday. The amendments would notably remove the requirement for cannabis products to be labeled as Schedule I controlled substances, reflecting recent federal rescheduling discussions
The proposed regulatory overhaul introduces a $5,000 application fee for businesses, annual license and renewal fees ranging from $10,000 to $28,500 depending on the license type, and a $13,000 charge for the state’s seed-to-sale tracking system. Dispensaries would also face new product licensing and renewal fees. Previously, Nebraska’s medical cannabis program did not require any such fees, and sales taxes remain prohibited under current law
Additional changes include merging transporter licenses with product manufacturers, making transportation an optional certification rather than a separate license. The commission emphasized the importance of stakeholder feedback: “Participants are encouraged to review the proposed amendments before the hearing and focus their comments on specific provisions they would like the commission to consider changing, clarifying, adding or removing,” the commission’s website states
Advocates worry that the proposed regulations could hinder access and growth for Nebraska’s medical cannabis program, especially after the legislature failed to pass new protections for healthcare providers this spring. The commission has also stated it will not license more establishments until the revised rules are approved by both the governor and attorney general, who are both up for reelection next month
OG Lab notes that Nebraska’s regulatory overhaul could set the tone for future cannabis policy in the region. With new fees and operational changes on the table, stakeholder engagement at this stage will be crucial for shaping a balanced and accessible program
